ZERGA, M. Bispecific antibodies in the treatment of relapsed/refractory diffuse large B cell lymphoma. Role of epcoritamab. Journal of Hematology, [S. l.], v. 29, n. 1, p. 11–21, 2025. DOI: 10.48057/hematologa.v29i1.639. Disponível em: https://mail.revistahematologia.com.ar/index.php/Revista/article/view/639. Acesso em: 18 nov. 2026.